Uric Acid (Serum Urate)
The gout marker with a metabolic story — and a crystal deposition twist
Best known for causing gout, uric acid is also a window into metabolic health. It rises with insulin resistance, kidney disease, and red meat consumption — and paradoxically, it can be normal during an acute gout attack.
Uric acid is the final oxidation product of purine metabolism in humans. Unlike most mammals, humans lack uricase (converting uric acid to the highly soluble allantoin) — a gene mutation occurring 15 million years ago. When serum urate exceeds the saturation point (~408 µmol/L), monosodium urate crystals precipitate in joints and soft tissues, triggering the exquisitely painful NLRP3 inflammasome-driven inflammation of gout.
Reference Ranges
How clinicians interpret Uric Acid (Serum Urate) results — from optimal to concerning.
⚠ Reference ranges vary by laboratory and assay. Always interpret your result in context of your laboratory's own reference intervals and your clinical presentation.
What raises Uric Acid (Serum Urate)
Dietary purines contribute ~30% of uric acid production. Beer (contains guanosine) has the strongest uricogenic effect among alcoholic drinks.
Reduce renal urate clearance by increasing tubular reabsorption — the most common drug cause of hyperuricaemia.
Massive cell death during chemotherapy releases DNA purines — uric acid surges and can cause acute kidney injury.
Reduced GFR reduces urate excretion — hyperuricaemia is near-universal in CKD stage 3+.
Fructose metabolism generates AMP, a purine substrate. Uniquely uricogenic — explains why sugary drinks strongly raise uric acid.
What lowers Uric Acid (Serum Urate)
Xanthine oxidase inhibitor — prevents uric acid synthesis. Titrate to urate < 360 µmol/L (< 300 µmol/L in tophaceous gout).
Promote renal urate excretion — reduce uric acid by 10–15% as a secondary cardiovascular-renal benefit.
Unique uricosuric property among ARBs — promotes urate excretion. Preferred antihypertensive in gout patients.
Adequate fluid intake (2–3 L/day) dilutes urine and promotes urate excretion — simplest lifestyle intervention.
Conditions this biomarker signals
When Uric Acid (Serum Urate) is outside normal range, these are the most clinically significant possibilities.
Urate > 360 µmol/L necessary (but not sufficient) for gout. Confirmation via joint aspiration showing monosodium urate crystals.
Urate > 480 + rising creatinine + hyperphosphatemia post-chemotherapy = TLS emergency. IV rasburicase required.
Uric acid is independently associated with insulin resistance, hypertension, and CVD — a potential cardiometabolic risk factor.
Which tests measure this biomarker
Uric Acid (Serum Urate) may be included in or ordered alongside these panels.
Can be normal during acute gout attack — crystals deposit from serum, paradoxically lowering level. Never exclude gout based on normal serum urate during flare.
Distinguishes overproducers (high urine urate) from underexcretors (low urine/high serum) — guides treatment choice (allopurinol vs uricosuric agent).
Why humans get gout and most animals don't: the missing uricase gene
Most mammals possess uricase (urate oxidase), converting uric acid to the highly soluble allantoin for easy excretion. Humans, great apes, and Dalmatians share a uricase gene mutation from 15 million years ago — making us uniquely susceptible to hyperuricaemia. The evolutionary advantage may have been that uric acid acts as an antioxidant and helped maintain blood pressure during periods of salt restriction. The trade-off is gout. Monosodium urate crystals activate the NLRP3 inflammasome in synovial macrophages, triggering caspase-1 activation and massive IL-1β release — explaining why colchicine and anakinra (anti-IL-1β) are effective in acute gout.
Crystal saturation point — the threshold that matters
Monosodium urate crystals precipitate when uric acid exceeds ~408 µmol/L (6.8 mg/dL) at physiological pH and temperature. Crystal deposition can be silent for years — gout attacks occur when crystals are shed into the joint space and engulfed by neutrophils, triggering the violent NLRP3 inflammasome-driven inflammatory response.
Gout is an NLRP3 inflammasome-driven disease
When urate crystals are phagocytosed, they activate the NLRP3 inflammasome — a cytosolic multiprotein complex triggering caspase-1 activation and massive IL-1β release. This is why colchicine (disrupting neutrophil migration and NLRP3 activation) and anakinra (anti-IL-1β) are effective, and why attacking uric acid production (allopurinol) is the preventive strategy.
Uric acid can fall during an acute gout attack
During a gout flare, serum urate may paradoxically normalise — crystals are depositing from serum, temporarily lowering the circulating level. This means a normal serum urate does not exclude active gout. Diagnosis is confirmed by joint aspiration: negatively birefringent needle-shaped crystals under polarised light microscopy, not by serum urate level.
Clinical use — when and why this is ordered
How clinicians use Uric Acid (Serum Urate) in practice — the real-world scenarios where it changes decisions.
Gout diagnosis and ULT monitoring
Serial urate guides allopurinol titration — increase dose until urate < 360 µmol/L (or < 300 µmol/L in tophaceous gout). Flares decrease once target is reached consistently.
TLS prevention pre-chemotherapy
Measured before high-tumour-burden lymphoma/leukaemia chemotherapy — allopurinol or rasburicase prophylaxis initiated based on baseline urate.
CKD monitoring
Near-universal hyperuricaemia in CKD — management reduces gout flare risk and may slow CKD progression in observational data.
Metabolic syndrome evaluation
Uric acid as part of metabolic syndrome assessment — alongside waist circumference, triglycerides, HDL, blood pressure, and fasting glucose.